Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 9/28/2025

Rosuvastatin and Berberine Interaction Management

Clinical Considerations

  • Early increases in liver enzymes occur in the first 4 weeks of statin therapy, especially with concomitant medications, according to the American Gastroenterological Association 1, 2

Laboratory Monitoring and Safety

  • The American Heart Association recommends checking creatine kinase levels if muscle symptoms develop during statin therapy 3
  • Baseline and periodic liver function tests should be considered due to potential hepatotoxicity, particularly when statins are combined with agents that increase their plasma concentrations, as suggested by the American College of Cardiology 3

Resumption and Monitoring

  • Once laboratory values are obtained and interpreted, rosuvastatin can be resumed if clinically appropriate, as per the American Gastroenterological Association 2
  • If continuing both rosuvastatin and berberine, monitor closely for signs of statin toxicity, including muscle symptoms and liver enzyme elevations, as recommended by the American Heart Association 3